Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHRD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CDH11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00112 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNX7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCOR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FILIP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALS2CR12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on